| Literature DB >> 32509521 |
Amie Steel1, Joshua Z Goldenberg1,2, Jason A Hawrelak1,3, Hope Foley1,4, Sophia Gerontakos1, Joanna E Harnett1,5, Janet Schloss1,4, Rebecca Reid4.
Abstract
BACKGROUND: Naturopathy is one of seven distinct traditional medical systems acknowledged by the World Health Organization. Naturopathic principles and philosophies encourage a focus on multiple body systems during case-taking and the design of treatments. Little is known about whether such teaching translates into practice. This study aimed to characterise naturopathic practice as it relates to the identification of multiple physiological systems in the diagnosis and treatment of patients.Entities:
Keywords: Integrative medicine; Integrative physiology; Naturopathy; Traditional and complementary medicine
Year: 2020 PMID: 32509521 PMCID: PMC7265055 DOI: 10.1016/j.imr.2020.100424
Source DB: PubMed Journal: Integr Med Res ISSN: 2213-4220
Participant Characteristics (n = 56)
| Characteristic | |
|---|---|
| Australia | 6 (10.7) |
| Brazil | 4 (7.1) |
| Canada | 6 (10.7) |
| Chile | 4 (7.1) |
| Hong Kong | 3 (5.4) |
| India | 7 (12.5) |
| Nepal | 2 (3.6) |
| New Zealand | 3 (5.4) |
| Portugal | 4 (7.1) |
| South Africa | 2 (3.6) |
| Spain | 4 (7.1) |
| Switzerland | 2 (3.6) |
| United Kingdom | 3 (5.4) |
| United States | 6 (10.7) |
| Female | 35 (62.5) |
| Male | 21 (37.5) |
| 26–35 years | 11 (19.6) |
| 36–45 years | 21 (37.5) |
| 46–55 years | 11 (19.6) |
| 56–65 years | 11 (19.6) |
| 66 years or more | 2 (3.6) |
| 5–10 years | 25 (44.6) |
| 11–15 years | 14 (25.0) |
| 16–20 years | 5 (8.9) |
| 21–25 years | 6 (10.7) |
| 26 years | 6 (10.7) |
| Less than 10 | 9 (16.1) |
| 11–20 | 20 (35.7) |
| 21–30 | 12 (21.4) |
| 31–40 | 8 (14.3) |
| 41–50 | 4 (7.1) |
| 51 or more | 3 (5.4) |
| Mean (SD; Min, Max) | |
| Average number of responses per participant | 15.1 (7.6; 1, 20) |
Characteristics of Patients Compared with Number of Physiological Systems Considered by the Participants to be Important in Management of the Patient's Health (n = 854)
| All patients ( | None ( | One ( | Two ( | Three ( | Four or more ( | Cramer's | IRR | 95% CI | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sex ( | |||||||||||
| Female | 618 (72.6) | 26 (70.3) | 198 (67.8) | 136 (78.2) | 113 (69.8) | 145 (78.0) | .1058 | .049 | – | ||
| Male | 233 (27.4) | 11 (29.7) | 94 (32.2) | 38 (21.8) | 49 (30.3) | 41 (22.0) | |||||
| Young child (0–4 years) | 21 (2.5) | 3 (8.3) | 10 (3.5) | 4 (2.3) | 3 (1.9) | 1 (0.6) | .1009 | .005 | Ref | – | – |
| Child (5–11 years) | 21 (2.5) | 1 (2.8) | 16 (5.6) | 2 (1.2) | 1 (0.6) | 1 (0.6) | .95 | .65–1.40 | .794 | ||
| Adolescent (12-17 years) | 10 (1.2) | 0 (0.0) | 6 (2.1) | 1 (0.6) | 2 (1.3) | 1 (0.6) | 1.2 | .8–2.0 | .455 | ||
| Working age (18–65 years) | 678 (81.2) | 31 (86.1) | 218 (76.0) | 143 (83.6) | 132 (83.0) | 154 (84.6) | 1.3 | 1.0–1.8 | .042 | ||
| Elderly (65 years and older) | 105 (12.6) | 1 (2.8) | 21 (12.3) | 21 (12.3) | 21 (13.2) | 25 (13.7) | 1.4 | 1.0–1.8 | .046 | ||
| First | 281 (33.0) | 11 (29.7) | 110 (37.4) | 52 (30.2) | 44 (27.5) | 64 (33.9) | .0812 | .229 | – | ||
| Follow up | 571 (67.0) | 26 (70.3) | 184 (62.6) | 120 (70.0) | 116 (72.5) | 125 (66.1) | |||||
| Acute | 165 (19.5) | 8 (22.9) | 82 (28.4) | 36 (20.7) | 21 (13.2) | 18 (9.6) | .1512 | <.001 | Ref | – | – |
| Chronic | 633 (75.0) | 26 (74.3) | 186 (64.4) | 128 (73.6) | 129 (81.1) | 164 (87.7) | 1.2 | 1.1–1.3 | .003 | ||
| Unsure | 46 (5.5) | 1 (2.9) | 21 (7.3) | 10 (5.8) | 9 (5.7) | 5 (2.7) | 1.0 | .8–1.3 | .767 | ||
| Musculoskeletal condition | 158 (18.4) | 13 (33.3) | 56 (19.0) | 37 (21.3) | 29 (17.8) | 23 (12.2) | .1170 | .019 | .90 | .8–1.0 | .051 |
| Gastrointestinal condition | 104 (12.1) | 6 (15.4) | 37 (12.6) | 23 (13.2) | 15 (9.2) | 23 (12.2) | .0477 | .745 | – | – | – |
| Mental health condition | 93 (10.8) | 3 (7.7) | 38 (12.9) | 23 (13.2) | 18 (11.0) | 11 (5.8) | .0946 | .104 | – | – | – |
| Wellness and condition | 57 (6.6) | 1 (2.6) | 27 (9.2) | 7 (4.0) | 12 (7.4) | 10 (5.3) | .0885 | .151 | – | – | – |
| Female reproductive condition | 51 (5.9) | 1 (2.6) | 17 (5.8) | 6 (3.5) | 12 (7.4) | 15 (7.9) | .0738 | .321 | – | – | – |
| Skin condition | 44 (5.1) | 3 (7.7) | 9 (3.1) | 13 (7.5) | 9 (5.5) | 10 (5.3) | .0774 | .273 | – | – | – |
| Respiratory condition | 43 (5.0) | 0 (0.0) | 22 (7.5) | 8 (4.6) | 5 (3.1) | 8 (4.2) | .0930 | .115 | – | – | – |
| Fertility condition | 43 (5.0) | 0 (0.0) | 11 (3.7) | 12 (6.9) | 9 (5.5) | 11 (5.8) | .074 | .319 | – | – | – |
| Neurological condition | 43 (5.0) | 1 (2.6) | 16 (5.5) | 10 (5.8) | 5 (3.1) | 11 (5.8) | .5024 | .670 | – | – | – |
| Endocrine condition | 40 (4.7) | 0 (0.0) | 6 (2.0) | 7 (4.0) | 14 (8.6) | 13 (6.9) | .1293 | .006 | – | – | – |
| Cancer-related condition | 39 (4.5) | 1 (2.6) | 13 (4.4) | 4 (2.3) | 4 (2.5) | 17 (9.0) | .1214 | .013 | – | – | – |
| Cardiovascular condition | 36 (4.2) | 2 (5.1) | 11 (3.7) | 5 (2.9) | 4 (2.5) | 14 (7.4) | .0908 | .132 | – | – | – |
| Weight management | 34 (4.0) | 2 (5.1) | 11 (3.7) | 6 (3.5) | 6 (3.7) | 9 (4.8) | .0275 | .957 | – | – | – |
| Autoimmune condition | 31 (3.6) | 2 (5.1) | 7 (2.4) | 7 (4.0) | 9 (5.5) | 6 (3.2) | .0632 | .488 | – | – | – |
| Urogenital condition | 21 (2.4) | 0 (0.0) | 7 (2.4) | 4 (2.3) | 6 (3.7) | 4 (2.1) | .0498 | .712 | – | – | – |
| Ageing or cognition condition | 10 (1.2) | 0 (0.0) | 3 (1.0) | 1 (0.6) | 4 (2.5) | 2 (1.0) | .0630 | .491 | – | – | – |
| Infectious condition | 7 (0.8) | 0 (0.0) | 2 (0.7) | 1 (0.6) | 2 (1.2) | 2 (1.0) | .034 | .911 | – | – | – |
| General practitioner | 369 (43.2) | 14 (40.0) | 101 (34.5) | 78 (44.8) | 81 (47.0) | 95 (50.3) | .1372 | .003 | 1.1 | 1.0–1.2 | .020 |
| Specialist doctor | 237 (27.8) | 9 (25.7) | 55 (18.8) | 52 (29.9) | 54 (33.1) | 67 (35.5) | .1538 | <.001 | 1.1 | 1.0–1.2 | .034 |
| Allied health practitioner | 106 (12.7) | 2 (5.7) | 31 (10.6) | 26 (14.9) | 23 (14.1) | 24 (12.7) | .0669 | .431 | – | – | – |
| Other complementary medicine practitioner | 93 (10.9) | 3 (8.6) | 23 (7.9) | 20 (11.5) | 23 (14.1) | 24 (12.7) | .0797 | .246 | – | – | – |
| No other health practitioner | 282 (33.0) | 14 (40.0) | 119 (40.6) | 53 (30.5) | 43 (26.4) | 53 (28.0) | .1294 | .006 | – | – | – |
| Gastrointestinal system | 348 (40.8) | 0 (0.0) | 48 (16.4) | 63 (36.2) | 99 (60.7) | 138 (73.0) | .4912 | <.001 | |||
| Endocrine system | 203 (23.8) | 0 (0.0) | 21 (7.2) | 41 (23.6) | 46 (28.2) | 95 (50.3) | .3909 | <.001 | |||
| Musculoskeletal system | 151 (17.7) | 0 (0.0) | 21 (7.2) | 26 (14.9) | 36 (22.1) | 68 (36.0) | .2989 | <.001 | |||
| Female reproductive system | 134 (15.7) | 0 (0.0) | 11 (3.8) | 30 (17.2) | 29 (17.8) | 64 (33.9) | .3175 | <.001 | |||
| Mental health | 132 (15.5) | 0 (0.0) | 29 (9.9) | 30 (17.2) | 27 (16.6) | 46 (24.3) | .1722 | <.001 | |||
| Cardiovascular system | 108 (12.7) | 0 (0.0) | 12 (4.1) | 11 (6.3) | 27 (16.6) | 58 (30.7) | .3223 | <.001 | |||
| Integumentary system | 79 (9.3) | 0 (0.0) | 9 (3.1) | 6 (3.5) | 15 (9.2) | 49 (25.9) | .3182 | <.001 | |||
| Autoimmune condition | 74 (8.7) | 0 (0.0) | 3 (1.0) | 5 (2.9) | 18 (11.0) | 48 (25.4) | .3428 | <.001 | |||
| Respiratory system | 71 (7.3) | 0 (0.0) | 7 (2.4) | 5 (2.9) | 15 (9.2) | 44 (23.3) | .3044 | <.001 | |||
| Ageing and cognition | 69 (8.1) | 0 (0.0) | 9 (3.1) | 10 (5.8) | 13 (8.0) | 37 (19.6) | .2368 | <.001 | |||
| Neurological system | 67 (14.3) | 0 (0.0) | 13 (4.4) | 12 (6.9) | 15 (9.2) | 27 (14.3) | .1498 | .001 | |||
| Urogenital system | 41 (4.8) | 0 (0.0) | 4 (1.4) | 1 (0.6) | 12 (7.4) | 24 (12.7) | .2277 | <.001 | |||
| Cancer | 29 (3.4) | 0 (0.0) | 7 (2.4) | 3 (1.7) | 0 (0.0) | 19 (10.1) | .2021 | <.001 | |||
Characteristics of Patients that Participants have Considered the Digestive System (n = 348) or Endocrine System (n = 204) as an Additional Factor to Consider in Management of the Patient's Health
| All participants ( | Digestive system ( | IRR | 95%CI | Endocrine system ( | IRR | 95%CI | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Female | 618 (72.6) | 145 (28.7) | .0401 | .243 | – | – | – | 160 (80.0) | .0904 | .009 | – | – | – |
| Male | 233 (27.4) | 86 (25.1) | – | – | – | 40 (20.0) | – | – | – | ||||
| Young child (0–4 years) | 21 (2.5) | 10 (3.0) | .0531 | .673 | – | – | – | 2 (1.0) | .1022 | .069 | – | – | – |
| Child (5–11 years) | 21 (2.5) | 8 (2.4) | – | – | – | 1 (0.5) | – | – | – | ||||
| Adolescent (12-17 years) | 10 (1.2) | 2 (0.6) | – | – | – | 2 (1.0) | – | – | – | ||||
| Working age (18–65 years) | 678 (81.2) | 275 (81.9) | – | – | – | 170 (87.2) | – | – | – | ||||
| Elderly (65 years and older) | 1 (2.8) | 41 (12.2) | – | – | – | 20 (10.3) | – | – | – | ||||
| First | 281 (33.0) | 104 (33.1) | .0519 | .130 | – | – | – | 70 (34.7) | .0185 | .590 | – | – | – |
| Follow up | 571 (67.0) | 241 (66.9) | – | – | – | 132 (65.4) | – | – | – | ||||
| Chronicity | – | – | – | – | – | – | |||||||
| Acute | 165 (19.5) | 50 (14.5) | .1149 | .004 | – | – | – | 26 (13.1) | .0900 | .033 | – | – | – |
| Chronic | 633 (75.0) | 279 (80.9) | – | – | – | 160 (80.8) | – | – | – | ||||
| Unsure | 46 (5.5) | 16 (4.6) | – | – | – | 12 (6.1) | – | – | – | ||||
| Gastrointestinal condition | 104 (12.1) | 35 (10.1) | .0538 | .116 | – | – | – | 21 (10.3) | .0313 | .360 | – | – | – |
| Respiratory condition | 43 (5.0) | 18 (5.2) | .0052 | .879 | – | – | – | 3 (1.5) | .0908 | .008 | 0.3 | 0.1–0.9 | .035 |
| Cardiovascular condition | 36 (4.2) | 14 (4.0) | .0079 | .816 | – | – | – | 15 (7.4) | .0882 | .010 | 4.0 | 2.0–8.3 | <.001 |
| Endocrine condition | 40 (4.7) | 25 (7.2) | .0981 | .004 | 2.3 | 1.1–4.5 | .020 | 16 (7.9) | .0845 | .014 | – | – | – |
| Female reproductive condition | 51 (5.9) | 20 (5.8) | .0079 | .818 | – | – | – | 25 (12.3) | .1495 | <.001 | 3.7 | 2.0–6.9 | <.001 |
| Musculoskeletal condition | 158 (18.4) | 47 (13.5) | .1067 | .002 | – | – | – | 21 (10.3) | .1173 | .001 | – | – | – |
| Skin condition | 44 (5.1) | 26 (7.5) | .0870 | .011 | 2.1 | 1.1–5.0 | .022 | 8 (3.9) | .0306 | .371 | – | – | – |
| Urogenital condition | 21 (2.4) | 6 (1.7) | .0394 | .250 | – | – | – | 2 (1.0) | .0531 | .120 | – | – | – |
| Autoimmune condition | 31 (3.6) | 19 (5.5) | .0811 | .018 | 2.3 | 1.0–5.0 | .035 | 9 (4.4) | .0240 | .483 | – | – | – |
| Cancer-related condition | 39 (4.5) | 21 (6.0) | .0583 | .088 | – | – | – | 11 (5.4) | .0228 | .505 | – | – | – |
| Fertility condition | 43 (5.0) | 13 (3.7) | .0493 | .150 | – | – | – | 21 (10.3) | .1356 | <.001 | 3.3 | 1.7–6.5 | .001 |
| Ageing or cognition condition | 10 (1.2) | 5 (1.5) | .0205 | .549 | – | – | – | 0 (0.0) | .0608 | .076 | – | – | – |
| Infectious condition | 7 (0.8) | 3 (0.9) | .0039 | .909 | – | – | – | 2 (1.0) | .0103 | .764 | – | – | – |
| Wellness and prevention | 57 (6.6) | 25 (7.2) | .0169 | .621 | – | – | – | 9 (4.4) | .0501 | .143 | – | – | – |
| Weight management | 34 (4.0) | 16 (4.6) | .0261 | .445 | – | – | – | 12 (5.9) | .0551 | .107 | – | – | – |
| Mental health condition | 93 (10.8) | 41 (11.8) | .0237 | .488 | – | – | – | 15 (7.4) | .0628 | .067 | – | – | – |
| Neurological condition | 43 (5.0) | 14 (4.0) | .0384 | .262 | – | – | – | 13 (6.4) | .0350 | .307 | – | – | – |
| General practitioner | 369 (43.2) | 167 (48.0) | .0800 | .019 | – | – | – | 88 (43.4) | .0016 | .963 | – | – | – |
| Specialist doctor | 237 (27.8) | 118 (33.9) | .1140 | .001 | 1.5 | 1.1–2.1 | .016 | 65 (32.0) | .0532 | .120 | – | – | – |
| Allied health practitioner | 106 (12.7) | 50 (14.4) | .0492 | .151 | – | – | – | 26 (12.8) | .0067 | .845 | – | – | – |
| Other complementary medicine practitioner | 93 (10.9) | 40 (11.5) | .0161 | .638 | – | – | – | 26 (12.8) | .0344 | .315 | – | – | – |
| No other health practitioner | 282 (33.0) | 104 (29.9) | .0553 | .106 | – | – | – | 60 (29.6) | .0411 | .229 | – | – | – |
| Gastrointestinal system | 348 (40.8) | 101 (49.8) | .1023 | .003 | 1.5 | 1.1–2.2 | .019 | ||||||
| Respiratory system | 71 (7.3) | 41 (11.8) | .1042 | .002 | – | – | – | 18 (8.9) | .0112 | .744 | – | – | – |
| Cardiovascular system | 108 (12.7) | 57 (16.4) | .0931 | .006 | 1.7 | 1.1–2.6 | .015 | 31 (15.3) | .0441 | .198 | – | – | – |
| Endocrine system | 203 (23.8) | 101 (29.0) | .1023 | .003 | – | – | – | ||||||
| Female reproductive system | 134 (15.7) | 70 (20.1) | .1009 | .003 | 1.6 | 1.1–2.4 | .020 | 60 (29.6) | .2129 | <.001 | 2.9 | 1.9–4.4 | <.001 |
| Musculoskeletal system | 151 (17.7) | 67 (19.3) | .0342 | .318 | – | – | – | 34 (16.8) | .0137 | .690 | – | – | – |
| Integumentary system | 79 (9.3) | 49 (14.1) | .1382 | <.001 | 2.0 | 1.2–3.3 | .008 | 28 (13.8) | .0875 | .011 | – | – | – |
| Urogenital system | 41 (4.8) | 22 (6.3) | .0590 | .085 | – | – | – | 14 (6.9) | .0547 | .110 | – | – | – |
| Autoimmune condition | 74 (8.7) | 50 (14.4) | .1681 | <.001 | 2.7 | 1.6–4.6 | <.001 | 29 (14.3) | .1116 | .001 | 2.4 | 1.4–4.2 | .002 |
| Cancer | 29 (3.4) | 15 (4.3) | .0419 | .221 | – | – | – | 9 (4.4) | .0320 | .350 | – | – | – |
| Ageing and cognition | 69 (8.1) | 30 (8.6) | .0165 | .630 | – | – | – | 16 (7.9) | .0041 | .906 | – | – | – |
| Wellness and prevention | 245 (28.7) | 115 (33.0) | .0799 | .020 | 1.5 | 1.1–2.0 | .016 | 48 (23.7) | .0623 | .069 | 0.7 | 0.5–1.0 | .042 |
| Mental health | 132 (15.5) | 51 (14.7) | .0184 | .591 | – | – | – | 19 (9.4) | .0942 | .006 | 0.4 | 0.3–0.7 | .002 |
| Neurological system | 67 (14.3) | 25 (7.2) | .204 | .551 | – | – | – | 17 (8.4) | .0110 | .748 | – | – | – |
IRR – Incident Rate Ratio.